Spotlight
Video

ABSTRACT #337: Bevacizumab (bev) in combination with capecitabine (cape) for the first-line treatment of elderly patients with metastatic colorectal cancer (mCRC): Results of a randomized international phase III trial (AVEX).

imedex has 1073 videos Subscribe Here

Loading........
Description: Axel Grothey discusses Abstract #337; Bevacizumab (bev) in combination with capecitabine (cape) for the first-line treatment of elderly patients with metastatic colorectal cancer (mCRC): Results of a randomized international phase III trial (AVEX). at ASCO GI meeting 2013.
Shared By : imedex
Posted on : 02/04/13
Added : 4 years ago
Category : Colorectal Cancer